AI Article Synopsis

  • - The influenza virus is more common in colder seasons, with challenges in detecting influenza B due to limited effectiveness of existing treatments against it.
  • - A new biosensor was developed that quickly and accurately detects the influenza B virus by utilizing specific DNA probes and electrochemical techniques.
  • - Testing showed that the biosensor correctly identified the influenza B genome, matching results from traditional real-time PCR, highlighting its potential for use in rapid virus detection in clinical settings.

Article Abstract

The influenza virus is a pervasive pathogen that exhibits increased prevalence during colder seasons, resulting in a significant annual occurrence of infections. Notably, pharmaceutical interventions effective against influenza A strains often exhibit limited efficacy against influenza B variants. Against this backdrop, the need for innovative approaches to accurately and swiftly differentiate and detect influenza B becomes evident. Biosensors play a pivotal role in this detection process, offering rapid, specific, and sensitive identification of the virus, facilitating timely intervention and containment efforts. Oligonucleotide sequences targeting the conserved B/Victoria/2/87 influenza virus NP region were designed. Nasopharyngeal swabs were collected from patients suspected of influenza virus infection, and viral RNA was extracted. RNA quality was assessed through one-step PCR. cDNA synthesis was performed using random hexamers, and real-time PCR quantified the influenza genome. Gold nanoparticles were immobilized on a surface to immobilize the specific DNA probe, and electrochemical hybridization was electrochemically followed. The biosensor exhibited high selectivity and effective distinction of complementary sequences from mismatches and influenza virus cDNA genome. The biosensor successfully detected the influenza B virus genome in real samples. Non-influenza samples yielded no significant hybridization signals. The comparison between the results obtained from the biosensor and real-time PCR revealed full agreement of these methods. The biosensor utilized electrochemical detection of hybridization and proved effective in detecting the influenza B virus genome with high specificity, sensitivity, and selectivity. Comparative analysis with real-time PCR underscored the accuracy and potential applicability of the biosensor in rapid and specific virus detection. This innovative approach holds promise for future diagnostic and epidemiological applications in detecting influenza B virus and other pathogens.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmr.3073DOI Listing

Publication Analysis

Top Keywords

influenza virus
28
influenza
12
real-time pcr
12
virus
9
gold nanoparticles
8
rapid specific
8
virus genome
8
detecting influenza
8
biosensor
6
nucleic acid-based
4

Similar Publications

[Molecular Ion Channel Blockers of Influenza A and SARS-CoV-2 Viruses].

Mol Biol (Mosk)

December 2024

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, 630090 Russia.

Molecules were proposed to block the functional cycles of the influenza virus A and SARS-CoV- 2. The blocker molecules efficiently bind inside the M2 and E channels of influenza A and SARS-CoV-2 viruses and block diffusion of H^(+)/K^(+) ions, thus distorting the virus functional cycle. A family of positively charged (+2 e.

View Article and Find Full Text PDF

Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants.

Semin Respir Crit Care Med

December 2024

South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Lower respiratory tract infection (LRTI) is a major cause of neonatal morbidity and mortality worldwide. Maternal vaccination is an effective strategy in protecting young infants from LRTI, particularly in the first few months after birth when infant is most vulnerable, and most primary childhood vaccinations have not been administered. Additionally, maternal vaccination protects the mother from illness during pregnancy and the postnatal period, and the developing fetus from adverse outcomes such as stillbirth and prematurity.

View Article and Find Full Text PDF

Shifts in seasonal influenza patterns in Australia during and after COVID-19: A comprehensive analysis.

J Infect Public Health

December 2024

Ecosystem Change and Population Health Research Group, School of Public Health and Social Work, Queensland University of Technology, Brisbane, Australia. Electronic address:

Background: During the COVID-19 pandemic, seasonal influenza virus circulation was heavily suppressed worldwide. In Australia, since the virus re-emerged in 2022, shifts in seasonal influenza patterns have been observed. Both the 2022 and 2023 seasons started earlier than pre-pandemic norms and were categorised as moderate to severe, highlighting the renewed importance of prevention strategies for seasonal influenza.

View Article and Find Full Text PDF

Respiratory viral infections have a considerable detrimental impact on animal health as well as significant financial consequences in the poultry industry. The primary aim of this study is to investigate the major pathogens involved in respiratory diseases of poultry, the co-infection rate, and their epidemiological distribution in commercial chicken farms in Bangladesh. From June 2022 to December 2023, 300 pooled samples (swabs from live birds, and respiratory tissues from dead birds) were collected from the selected poultry farms where respiratory outbreaks were noticed.

View Article and Find Full Text PDF

Gene flow and its sporadic spillover: H10 and N5 avian influenza viruses from wild birds and the H10N5 human cases in China.

Virol Sin

December 2024

School of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China. Electronic address:

On 30 January 2024, China announced the first human case of H10N5 influenza infection. Prior to this, human cases of H10N7 and H10N8 had been reported. It is now appropriate to re-examine the evolution and future epidemiological trends of the H10 and N5 subtypes of avian influenza viruses (AIVs).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!